Literature DB >> 3802952

Pharmacokinetics of ceftriaxone in serum and gynecological tissues.

P De Grandi, J F Bauen.   

Abstract

In order to evaluate the pharmacokinetics of ceftriaxone (Rocephin) in serum and gynecological tissues, intravenous injections of 2 g of ceftriaxone were administered to 3 groups, numbering 6 patients each, at 2-, 12-, and 24-hour intervals prior to surgery (hysterectomy and annexectomy) for noninfectious pathology. Even 24 h after intravenous administration of 2 g of ceftriaxone, both serum and gynecological tissue concentrations are well above the MIC90 for the majority of pathogens responsible for gynecological infections excepting Streptococcus faecalis and Bacteroides fragilis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3802952     DOI: 10.1159/000238455

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

Review 1.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

3.  Pharmacokinetics and protein binding of ceftriaxone during pregnancy.

Authors:  P Bourget; H Fernandez; V Quinquis; C Delouis
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics of ceftriaxone.

Authors:  J H Yuk; C H Nightingale; R Quintiliani
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.